BR112017002580A2 - administração de antioxidantes bioativos nanoencapsulados - Google Patents
administração de antioxidantes bioativos nanoencapsuladosInfo
- Publication number
- BR112017002580A2 BR112017002580A2 BR112017002580A BR112017002580A BR112017002580A2 BR 112017002580 A2 BR112017002580 A2 BR 112017002580A2 BR 112017002580 A BR112017002580 A BR 112017002580A BR 112017002580 A BR112017002580 A BR 112017002580A BR 112017002580 A2 BR112017002580 A2 BR 112017002580A2
- Authority
- BR
- Brazil
- Prior art keywords
- antioxidant
- nanoparticles
- bioactive
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462035683P | 2014-08-11 | 2014-08-11 | |
| US201562172455P | 2015-06-08 | 2015-06-08 | |
| PCT/US2015/044483 WO2016025394A2 (en) | 2014-08-11 | 2015-08-10 | Delivery of bioactive, nanoencapsulated antioxidants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017002580A2 true BR112017002580A2 (pt) | 2018-03-27 |
Family
ID=55304745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017002580A BR112017002580A2 (pt) | 2014-08-11 | 2015-08-10 | administração de antioxidantes bioativos nanoencapsulados |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10292943B2 (enExample) |
| EP (1) | EP3179988A4 (enExample) |
| JP (1) | JP6668327B2 (enExample) |
| KR (1) | KR102218883B1 (enExample) |
| AP (1) | AP2017009684A0 (enExample) |
| AU (1) | AU2015301945B2 (enExample) |
| BR (1) | BR112017002580A2 (enExample) |
| CA (1) | CA2992879C (enExample) |
| EA (1) | EA035620B1 (enExample) |
| MX (1) | MX388028B (enExample) |
| WO (1) | WO2016025394A2 (enExample) |
| ZA (1) | ZA201700987B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA035620B1 (ru) * | 2014-08-11 | 2020-07-16 | Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж | Способы и композиция для лечения или профилактики катаракты |
| WO2019148140A2 (en) * | 2018-01-26 | 2019-08-01 | Wu Joseph C | Implantable biomaterials that enhance stem cell survival and function |
| US20220257521A1 (en) * | 2019-06-14 | 2022-08-18 | Folium Biosciences Europe B.V. | Method for micro-encapsulation of natural ingredients by means of contacting with supercritical gas |
| JP2023526040A (ja) * | 2020-05-11 | 2023-06-20 | オプ２ライシス | 血栓性または出血性疾患の治療に使用するための徐放性プラスミノーゲン活性化因子製剤 |
| US11298321B1 (en) | 2021-07-12 | 2022-04-12 | King Abdulaziz University | Methods for treating metabolic disorder |
| US11253481B1 (en) | 2021-07-12 | 2022-02-22 | King Abdulaziz University | Self-nanoemulsifying 3D-printed tablet composition and method of use thereof |
| KR102824097B1 (ko) | 2022-12-07 | 2025-06-24 | 주식회사 엘지생활건강 | 바이오틴이 담지된 나노파티클 및 이의 제조 방법, 및 이의 용도 |
| WO2025106389A1 (en) * | 2023-11-13 | 2025-05-22 | Universitatea De Medicină Şi Farmacie Iluiu Haţieganu | New forms of lutein and their uses |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2011423A1 (en) * | 1989-03-07 | 1990-09-07 | Peter M. Taylor | Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings |
| US6573299B1 (en) * | 1999-09-20 | 2003-06-03 | Advanced Medical Instruments | Method and compositions for treatment of the aging eye |
| US6703039B2 (en) * | 2000-12-06 | 2004-03-09 | Bausch & Lomb Incorporated | Reversible gelling system for ocular drug delivery |
| DE10141018A1 (de) * | 2001-08-22 | 2003-03-13 | Eth Zuerich Eidgenoessische Te | Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges |
| US20040009212A1 (en) * | 2002-01-30 | 2004-01-15 | Pharma Power Biotec Co. Ltd. | Mucoadhesive thermoresponsive medicament-carrier composition |
| WO2003103549A1 (en) * | 2002-06-05 | 2003-12-18 | University Of Florida | Ophthalmic drug delivery system |
| RU2008119234A (ru) | 2005-10-16 | 2009-11-27 | Ликорд Лтд. (Il) | Композиции для лечения глазных заболеваний |
| WO2008137831A1 (en) * | 2007-05-07 | 2008-11-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Water-soluble nanoparticles containing water-insoluble compounds |
| DK2594140T3 (da) * | 2010-07-16 | 2019-06-03 | Univ Navarra | Nanopartikler til indkapsling af forbindelser, fremstilling og anvendelse deraf |
| MY157513A (en) * | 2010-09-03 | 2016-06-15 | Santen Sas | A water-in-oil type emulsion for treating a disease of the eye |
| EP2678007A4 (en) * | 2011-02-25 | 2015-08-12 | Univ South Dakota | PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION |
| US20120231072A1 (en) * | 2011-03-11 | 2012-09-13 | Chemisches Institut Schaefer Ag | Thermo-responsive hydrogel compositions |
| CN103845278B (zh) * | 2012-11-30 | 2016-06-22 | 沈阳药科大学 | 一种叶黄素眼用纳米乳-温度敏感型原位凝胶及其制备方法 |
| EA035620B1 (ru) * | 2014-08-11 | 2020-07-16 | Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж | Способы и композиция для лечения или профилактики катаракты |
-
2015
- 2015-08-10 EA EA201790361A patent/EA035620B1/ru unknown
- 2015-08-10 AP AP2017009684A patent/AP2017009684A0/en unknown
- 2015-08-10 WO PCT/US2015/044483 patent/WO2016025394A2/en not_active Ceased
- 2015-08-10 BR BR112017002580A patent/BR112017002580A2/pt not_active Application Discontinuation
- 2015-08-10 CA CA2992879A patent/CA2992879C/en active Active
- 2015-08-10 MX MX2017001903A patent/MX388028B/es unknown
- 2015-08-10 EP EP15831551.5A patent/EP3179988A4/en active Pending
- 2015-08-10 JP JP2017505869A patent/JP6668327B2/ja active Active
- 2015-08-10 KR KR1020177003119A patent/KR102218883B1/ko active Active
- 2015-08-10 US US15/502,415 patent/US10292943B2/en active Active
- 2015-08-10 AU AU2015301945A patent/AU2015301945B2/en active Active
-
2017
- 2017-02-03 ZA ZA2017/00987A patent/ZA201700987B/en unknown
-
2019
- 2019-04-30 US US16/399,388 patent/US10952974B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170216221A1 (en) | 2017-08-03 |
| US20190254987A1 (en) | 2019-08-22 |
| ZA201700987B (en) | 2019-05-29 |
| US10952974B2 (en) | 2021-03-23 |
| JP2017523983A (ja) | 2017-08-24 |
| AP2017009684A0 (enExample) | 2017-01-31 |
| EA201790361A1 (ru) | 2017-06-30 |
| EP3179988A2 (en) | 2017-06-21 |
| CA2992879C (en) | 2022-10-25 |
| EA035620B1 (ru) | 2020-07-16 |
| US10292943B2 (en) | 2019-05-21 |
| WO2016025394A2 (en) | 2016-02-18 |
| AU2015301945A1 (en) | 2017-03-09 |
| WO2016025394A3 (en) | 2016-05-19 |
| MX2017001903A (es) | 2017-09-26 |
| CA2992879A1 (en) | 2016-02-18 |
| JP6668327B2 (ja) | 2020-03-18 |
| EP3179988A4 (en) | 2018-11-14 |
| MX388028B (es) | 2025-03-19 |
| KR20170097601A (ko) | 2017-08-28 |
| KR102218883B1 (ko) | 2021-02-23 |
| AU2015301945B2 (en) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017002580A2 (pt) | administração de antioxidantes bioativos nanoencapsulados | |
| MX2018001487A (es) | Compuestos derivados de 1,3,4-oxadiazol como inhibidores de histona desacetilasa 6 y la composición farmacéutica que comprende los mismos. | |
| MX2017017090A (es) | Compuestos derivados de sulfamida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos. | |
| MX2017015938A (es) | Inhibidores de ezh2 para el tratar linfomas. | |
| MX2021009673A (es) | Moduladores de ror-gamma. | |
| EP4371616A3 (en) | Compositions of obeticholic acid and methods of use | |
| MX2018014124A (es) | Aposito para heridas o para la piel. | |
| AU2018270408A1 (en) | Methods of inhibiting aging and treating aging-related disorders | |
| WO2016113357A8 (en) | Proteasome inhibitors for treating a disorder related to an accumulation of non-degraded abnormal protein or a cancer | |
| EP3880304B8 (en) | Compositions for treating oxidative stress-associated skin diseases and skin ageing | |
| MX2016012262A (es) | Cenicriviroc para el tratamiento de fibrosis. | |
| MX2017009532A (es) | Uso de acidos grasos de cadena corta en prevencion de cancer. | |
| MX2018001196A (es) | Compuesto derivado de amida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6 y composición farmacéutica que lo contiene. | |
| BR112017010074A2 (pt) | preenchimento dérmico a base de ácido hialurônico reticulado e lubrificante de carboximetilcelulose | |
| EP3188688A4 (en) | Methods and biocompatible compositions to achieve sustained drug release in the eye | |
| EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
| HK1252771A1 (zh) | 用於治疗眼部病状的玻璃体内药物递送系统 | |
| EP3606570B8 (en) | Collagen peptide-based medicament compositions for use in the treatment of ocular diseases, disorders or wounds | |
| PL3678673T3 (pl) | Kompozycje i sposoby do ukierunkowanego dostarczania, ekspresji i modulowania kodujących kwasów rybonukleinowych w tkankach | |
| MX2022005370A (es) | Analogos de compstatina de accion prolongada para usarse en el tratamiento de trastornos oculares. | |
| PH12016501527B1 (en) | Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
| MX376473B (es) | Composicion para tratar lesiones cerebrales. | |
| EP3193867A4 (en) | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | |
| MX378586B (es) | Composición y método para el tratamiento de padecimientos de la piel | |
| EP3167893A4 (en) | Pharmaceutical composition containing spirulina maxima extract as active ingredient for preventing and treating retinal diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |